US89237H3084 - Common Stock
TRACON PHARMACEUTICALS INC
NASDAQ:TCON (5/8/2024, 7:21:32 PM)
1.76
-0.06 (-3.3%)
TRACON Pharmaceuticals, Inc. engages in the development and commercialization of targeted therapies for cancer, and ophthalmic and fibrotic diseases. The company is headquartered in San Diego, California and currently employs 18 full-time employees. The company went IPO on 2015-01-30. The firm is focused on the development and commercialization of targeted therapeutics for cancer. The Company’s lead product candidate, envafolimab, is a PD-L1 antibody that is being developed for the treatment of sarcoma. The Company’s other product candidates are YH001, a CTLA-4 antibody that is in Phase I/II development for the treatment of sarcoma; TRC102, a small molecule that is in Phase II clinical development for the treatment of mesothelioma; TJ004309, a CD73 antibody that is in Phase I testing, that is being developed through a collaboration with I-Mab Biopharma, and multiple bispecific antibody programs in preclinical development that are being developed through a collaboration with I-Mab Biopharma. The firm offers partners a solution for the clinical development and commercialization of their products in the United States.
TRACON PHARMACEUTICALS INC
4350 La Jolla Village Drive, Suite 800
San Diego CALIFORNIA 92122
P: 18585500780
CEO: Charles P. Theuer
Employees: 18
Website: https://www.traconpharma.com/
SAN DIEGO, May 07, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals, Inc. (Nasdaq: TCON), a clinical stage biopharmaceutical company utilizing a...
We are starting the trading week with a dive into the biggest pre-market stock movers worth keeping tabs on for Monday morning!
Explore three penny stocks primed for significant growth, backed by Strong Buy ratings from Wall Street. Play it high-risk.
SAN DIEGO, April 08, 2024 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ: TCON), a clinical stage biopharmaceutical company utilizing a...
Here you can normally see the latest stock twits on TCON, but your cookie settings prevent this from loading. You can edit your cookie settings in our cookie consent dialog.
Example Twits: